Listen: Biogen, Biogen, Biogen, with a dash of Omicron
On this episode of ‘The Readout LOUD,’ STAT’s biotech podcast, hear about the blockbuster STAT story on Biogen.
As genetic testing expands, evidence and awareness needed to spur adoption
Genetic tests are becoming available for a wider range of applications. During a CB Insights panel discussion, Phil Febbo of Illumina and Alicia Zhou of Color explained what they think needs to happen…
At biotech VCs, collecting ‘consulting fees’ from startups is widespread
Some of the biggest names in biotech venture capital have charged their startups millions of dollars in ‘consulting fees’ over the past decade.
Biotech VC firms charge their startups ‘consulting’ fees
AbbVie agreed to pay $200 million to resolve allegations made by New York state and two counties the company helped fuel the opioid crisis.
FDA expands authorization for Pfizer’s Covid booster to cover some teens
The authorization now extends to 16- and 17-year-olds, making Pfizer’s the only booster currently available in the U.S. for the age group.
Hospitals, physicians sue Biden administration over surprise billing
The nation’s largest physician and hospital lobbies are suing the Biden administration over regulations about banning surprise medical bills.
The U.S. is at a Kasserine Pass moment for Covid leaders
The stinging defeat of U.S. troops at the Kasserine Pass in Word War II offer lessons for the next round of fighting the Covid-19 pandemic
Eating disorder researchers say CDC data gap has left them flying blind
For almost a decade, federal public health officials have not collected nationally representative data on eating disorder prevalence in youth.
Transformation towards resilient sponge cities in China
China’s national Sponge City Program promotes the integration of green–grey–blue infrastructure for sustainable urban-water governance. However, recent record-breaking flood events have called the efficacy of the programme into question, illustrating the need for a holistic social–natural–engineering strategy to manage future climate uncertainties.
Include biodiversity representation indicators in area-based conservation targets
Advances in spatial biodiversity science and nationally available data have enabled the development of indicators that report on biodiversity outcomes, account for uneven global biodiversity between countries, and provide direct planning support. We urge their inclusion in the post-2020 global biodiversity framework.